Why the study?
The study aims to summarize current case reports, patterns, and mortality associated with myasthenic crisis complicated by Takotsubo cardiomyopathy.
Does Takotsubo cardiomyopathy in myasthenia gravis patients have a high mortality rate?
Does Takotsubo cardiomyopathy in myasthenia gravis patients have a high mortality rate?
This case report and review highlights the clinical presentation and mortality risk of Takotsubo cardiomyopathy occurring during myasthenic crisis.
Possible Takotsubo in myasthenia gravis warrants vigilance; case report leaves open causal link.
Myasthenia gravis is an autoimmune disorder in which antibodies are formed against post-synaptic nicotinic acetylcholine receptors that lead to impeded muscle contraction and commonly affects the oculomotor muscles. Takotsubo cardiomyopathy (TTC) is a dilated cardiomyopathy that can mimic a myocardial infarction and causes reversible systolic dysfunction. This is a case of a 66-year-old Caucasian male with a known history of ocular myasthenia gravis that presented to the emergency room with worsening dyspnea secondary to a myasthenic crisis. One day, following admission, his shortness of breath failed to improve and was found to meet the diagnostic criteria for takotsubo cardiomyopathy. A brief review of 31 previous cases summarizes the current case reports, patterns, and mortality associated with the myasthenic crisis associated with TTC.
No takes yet. Share an insight, caveat, or question.
Gayfield et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: